Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes

BACKGROUND: Recent studies suggest that immunotherapy using T regulatory cells (Tregs) prolongs remission in type 1 diabetes (T1DM). Here, we report factors that possibly affect the efficacy of this treatment. METHODS: The metabolic and immune background of 12 children with recently diagnosed T1DM,...

Descripción completa

Detalles Bibliográficos
Autores principales: Marek-Trzonkowska, Natalia, Myśliwiec, Małgorzata, Iwaszkiewicz-Grześ, Dorota, Gliwiński, Mateusz, Derkowska, Ilona, Żalińska, Magdalena, Zieliński, Maciej, Grabowska, Marcelina, Zielińska, Hanna, Piekarska, Karolina, Jaźwińska-Curyłło, Anna, Owczuk, Radosław, Szadkowska, Agnieszka, Wyka, Krystyna, Witkowski, Piotr, Młynarski, Wojciech, Jarosz-Chobot, Przemysława, Bossowski, Artur, Siebert, Janusz, Trzonkowski, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131539/
https://www.ncbi.nlm.nih.gov/pubmed/27903296
http://dx.doi.org/10.1186/s12967-016-1090-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131539/
https://www.ncbi.nlm.nih.gov/pubmed/27903296
http://dx.doi.org/10.1186/s12967-016-1090-7

Ejemplares similares